Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.

Abstract : Enteric-coated mycophenolate sodium (EC-MPS) is therapeutically equivalent to mycophenolate mofetil, but delays release of mycophenolic acid until it reaches the small intestine. De novo renal transplant patients taking part in a 12-month, multicenter, randomized study received cyclosporine microemulsion (CsA-ME, early or delayed to day 6), EC-MPS, steroids, and interleukin-2 antagonist induction. Tolerability data relating to EC-MPS are reported. Ninety-seven patients were randomized to early CsA-ME and 100 patients to delayed CsA-ME. Median daily dose of EC-MPS was 1440 mg at all time points throughout the 12-month period. The most frequently reported adverse events were constipation, anemia, urinary tract infection, abdominal pain, leukopenia, and cytomegalovirus infection; there were four malignancies. Fifty patients (24.6%) discontinued EC-MPS prematurely by 12 months, including 42 patients (84%) who discontinued owing to adverse events. No patient discontinued treatment because of gastrointestinal adverse events. Two-thirds of patients (137 [67.5%]) maintained full EC-MPS dose throughout the 12-month study and did not require any dose reduction or dose interruption. EC-MPS is well tolerated in de novo renal transplant recipients when administered in combination with CsA-ME and steroids, with low rates of dose reductions or interruptions. Gastrointestinal adverse events were responsible for dose reduction or interruption in only 5% of patients.
Type de document :
Article dans une revue
Transplantation Proceedings, Elsevier, 2006, 38 (9), pp.2860-3. 〈10.1016/j.transproceed.2006.08.119〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00473411
Contributeur : Philippe Saas <>
Soumis le : jeudi 15 avril 2010 - 11:26:59
Dernière modification le : jeudi 15 février 2018 - 08:48:14

Identifiants

Collections

Citation

Lionel Rostaing, Georges Mourad, Nassim Kamar, Valérie Garrigue, Alexandre Karras, et al.. Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.. Transplantation Proceedings, Elsevier, 2006, 38 (9), pp.2860-3. 〈10.1016/j.transproceed.2006.08.119〉. 〈inserm-00473411〉

Partager

Métriques

Consultations de la notice

118